Cyclosporine immunosuppression is a mainstay of organ transplantation. Outpatient prescriptions for cyclosporine can approach $1000 a month. Generic cyclosporine has been shown to be bioequivalent to the brand name Neoral in normal subjects, kidney transplant recipients at least 6 months after transplant and in newly transplanted kidney recipients. This protocol is the first attempt to show bioequivalence of generic cyclosporine and Neoral in liver transplant recipients.
Showing the most recent 10 out of 674 publications